Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate
These highlights do not include all the information needed to use NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS AND FERROUS FUMARATE TABLETS safely and effectively. See full prescribing information for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS AND FERROUS FUMARATE TABLETS. NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL tablets and ferrous fumarate tablets, for oral use Initial U.S. Approval: 1968
Approved
Approval ID
d4fa03d8-0ae0-497f-ba4e-76f03fd7a3ab
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 18, 2023
Manufacturers
FDA
Amneal Pharmaceuticals NY LLC
DUNS: 123797875
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate
PRODUCT DETAILS
NDC Product Code60219-1031
Application NumberANDA207514
Marketing CategoryC73584
Route of AdministrationN/A
Effective DateJuly 6, 2023
Generic NameNorethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate